Reuters logo
BRIEF-Successful phase III trial for Alk's tree allergy Slit-Tablet
September 14, 2017 / 11:24 AM / in 2 months

BRIEF-Successful phase III trial for Alk's tree allergy Slit-Tablet

Sept 14 (Reuters) - Alk-abello A/S:

* Successful phase III trial for Alk’s tree allergy slit-tablet

* Alk-Abello A/S - ‍results of trial were highly statistically significant​

* Alk-Abello - trial showed that treatment was well-tolerated by patients, with no new or unexpected adverse events reported

* Alk-Abello - trial met its primary efficacy endpoint​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below